Curis

Curis Earnings: Here’s Why Shares are Down Now
Wall St. Cheat Sheet
Mon, 08/5/13 - 09:29 am
earnings
Curis
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Arqule
Array Biopharma
Celldex
Aveo Pharmaceutical
Curis
Exelixis
MorphoSys
Genmab
Novartis
Incyte
Seattle Genetics
YM BioSciences
5 Pharmaceutical Companies With EMA Catalysts During The Next 3-12 Months
Seeking Alpha
Fri, 08/31/12 - 12:51 pm
Affymax
Arena Pharmaceuticals
Avanir
Curis
Dendreon
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
ASCO
Arqule
Array Biopharma
Astex
AstraZeneca
Bristol-Myers Squibb
GSK
Curis
Exelixis
Pfizer
Immunogen
Seattle Genetics
Sanofi
Synta
Curis Operable BCC Human Data: Early Results And Further Commentary
Seeking Alpha
Sun, 04/15/12 - 12:23 pm
Erivedge
Curis
Roche
basal cell carcinoma
4 Biotech Stocks Trading At A Steep Discount To Target Price
Seeking Alpha
Sun, 03/4/12 - 11:58 am
OncoGenex
Corcept Therapeutics
Curis
Questcor Pharmaceuticals
The 9 Biotechs With The Highest Growth Expectations
Seeking Alpha
Sat, 02/4/12 - 03:30 pm
Theratechnologies
SeraCare Life Sciences
Gentium
Curis
BioDelivery Sciences
Amarin
Affymetrix
Affymax
Vertex Pharmaceuticals
FDA Approves Roche, Curis Skin-Cancer Drug
TheStreet.com
Mon, 01/30/12 - 03:57 pm
Curis
Roche
FDA
skin cancer
Erivedge
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha
Mon, 12/12/11 - 11:14 am
FDA
Fentanyl SL
INSYS Therapeutics
Dapagliflozin
Bristol-Myers Squibb
Prochieve
Columbia Laboratories
Discovery Labs
Surfaxin
NeurogesX
Qutenza
Curis
Roche
vismodegib
Chelsea Therapeutics
Northera
ONYX Pharmaceuticals
Carfilzomib
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Curis Earns $8 Million Milestone As NDA Accepted By FDA
Seeking Alpha
Thu, 11/10/11 - 01:08 pm
Curis
milestone payments
FDA
basal cell carcinoma
Genentech
vismodegib
Mid-size biotechs making their way
Boston Globe, MA
Sun, 10/23/11 - 11:56 am
Vertex Pharmaceuticals
Ariad Pharmaceuticals
Ironwood
Curis
A Myriad of Biotech Catalysts Possible at Rodman & Renshaw 2011
CP Wire
Mon, 09/12/11 - 10:34 am
Curis
Rodman & Renshaw
BioSante
Cardium
CytoSorbents
NeurogesX
Supergen
Repros Therapeutics
Curis: Next Week's Data Release Could Bring Volatility to Shares
Seeking Alpha
Sat, 06/18/11 - 10:02 am
Curis
basal cell carcinoma
hedgehog pathway inhibitor
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche
Roche, Curis Drug Prevented Lesions, Reduced Tumor Size in Trial
Bloomberg
Fri, 04/1/11 - 11:32 am
Roche
Curis
skin cancer
vismodegib
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
ASCO
Medivation
Exelixis
Dendreon
Bristol-Myers Squibb
Roche
Curis
Celgene
Sanofi
Ariad Pharmaceuticals
Merck
Incyte
Novartis
YM BioSciences
Pfizer
Aveo Pharmaceutical
ONYX Pharmaceuticals
Amgen
Synta
Vical
Oxigene
Cell Therapeutics
Oncothyreon
Let's See Some Data, Curis
Motley Fool
Tue, 03/22/11 - 09:26 am
Curis
vismodegib
skin cancer
Roche, Curis Skin Cancer Drug Advances
TheStreet.com
Mon, 03/21/11 - 11:25 am
skin cancer
Roche
Curis
9 Biotech Stocks for 2011
Seeking Alpha
Fri, 01/14/11 - 09:50 am
Cepheid
Cerus
Curis
Illumina
Questcor Pharmaceuticals
CompuGen
Spectrum Pharmaceuticals
Impax
Human Genome Sciences
Vertex Pharmaceuticals
Orexigen
Dendreon

Pages